The UK puberty blocker trial is an ethical breach and a threat to trans youth’s health and rights

The recently announced PATHWAYS clinical trial protocol on puberty blockers (also known as puberty suppressing hormones) for young trans people in the UK represents a deeply troubling escalation in the erosion of young trans people’s rights and mental and physical health. 

In Italy a draft law proposes to redesign access to trans-specific healthcare for trans people under the age of 18.

Together with our partner organisations IGLYO — The International Youth & Student Organisation, ILGA-Europe, and OII Europe, we have put forward recommendations and priorities to protect LGBTQI youth from cyberbullying in this policy brief.

We call on the UK government to reconsider this harmful decision and to engage meaningfully with both the medical and scientific community and civil society groups representing the interests of trans youth and trans adults. 

Explore our work advocating for the rights of trans youth, family, and trans parents in Europe & Central Asia.

The European Court of Human Rights ruled that trans parents' legally recognised gender and name do not need to be used in children's birth certificates.

The European Court of Human Rights stroke out of its list of cases the of a trans mother who was denied registration in her child’s birth certificate.

The contested law prohibits positive depiction of homosexuality and gender reassignment towards children.

Explore TGEU's 'Jumping ropes' report on trans parenthood, which sheds light on the difficult situations trans parents find themselves in.

The Court of Appeal in the United Kingdom allows trans youths to access healthcare without the requirement of prior judicial approval.

The European Parliament adopted a historic resolution strengthening the rights of families of LGBTI persons this week.

Our comments on the case of a Russian trans man whose two foster children were removed from his home on account of his gender identity and transition.